As of May 23, 2025, Kadmon Holdings Inc (KDMN) reports a EV/EBITDA of -16.11.
EV/EBITDA evaluates a company's total value relative to its earnings before interest, taxes, depreciation, and amortization, useful for comparing firms with different capital structures.
Comparing Kadmon Holdings Inc's EV/EBITDA to Peers
To better understand Kadmon Holdings Inc's position, it's useful to compare its EV/EBITDA against industry peers. Below are selected comparisons:
| Company | EV/EBITDA |
|---|---|
| Kadmon Holdings Inc (KDMN) | -16.11 |
| MannKind Corp (MNKD) | 22.66 |
| Abbvie Inc (ABBV) | 17.94 |
| Theratechnologies Inc (TH.TO) | 15.57 |
| Regeneron Pharmaceuticals Inc (REGN) | 14.71 |
| Amgen Inc (AMGN) | 14.64 |
Compared to its competitors, Kadmon Holdings Inc's EV/EBITDA is among the lowest compared to peers, which may indicate undervaluation or market concerns about future performance.